Abu Dhabi Securities Exchange (ADX) Announces Issuing the First Sustainability Report During the First Half of 2020
14.1.2020 20:03:00 EET | Business Wire | Press release
ADX is participating in the "Second Abu Dhabi Sustainable Finance Forum" held under the umbrella of "Abu Dhabi Sustainability Week 2020", one of the world's most prominent sustainability events which takes place in the capital Abu Dhabi from 11th to 18th of January 2020.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200114005680/en/
H.E. Khalifa Salem Al Mansouri, Chief Executive of ADX (Photo: AETOSWire)
ADX is one of the signatories of the "Abu Dhabi Sustainable Finance Declaration", and a member of the "United Nations Sustainable Stock Exchange Initiative" (SSE). Today, Abu Dhabi Securities Exchange (ADX) announced that it will issue its first Environmental, Social & Governance (ESG) report in the first half of 2020. The report will be issued annually and is the first of its kind in the region.
The announcement comes few months after ADX issued a set of ESG disclosure guidelines to encourage listed companies to follow its lead and incorporate ESG issues into their business to test their effectiveness and act upon it. This will encourage listed companies to issue their sustainability reports, and it illustrates ADX’s commitment to drive sustainability in financial markets.
ADX is looking forward to an active participation in the discussions of the forum, which serves as an important opportunity to meet with different leaders around the world. ADX will discuss ways to integrate sustainability within the regulatory frameworks of investment institutions and cooperation with local and international sector leaders. This will enhance communication, knowledge and awareness in the field of sustainable financing, and will also help to explore Current and future opportunities for both sustainable finance and capital investment sectors, to obtain positive economic, social and environmental outcomes.
H.E. Khalifa Salem Al Mansouri, Chief Executive of ADX, said: “One of ADX’s strategic objectives is to advance Sustainable Development Goals (SDGs) through Sustainable Finance. Today I am proud to announce that ADX will release its first annual Environmental, Social & Governance (ESG) report in the first half of 2020. The report is instrumental in advancing our Sustainable Finance Agenda and promoting high sustainability standards. It also marks a significative step towards enhancing ADX's competitiveness and attracting more sustainable investments to Abu Dhabi.”
His Excellency continued: "In line with the growing investments made to companies that implements environmental, social and corporate governance, we aim to develop and position ADX as a vibrant and thriving sustainable investment hub that supports capital formation, raising and deployment as well as the creation and issuance of products to achieve positive economic, social and environmental objectives.”
His Excellency added: “Companies' commitments to developing strategies that integrate the standards of the report opens the way for investments supported by US$83 Trillion from various Asset Management Funds (AMC). These funds will be directed to companies that apply environmental, social and corporate governance standards. New Financial instruments and policies are among the instrumental components that will make up sustainable finance and ADX’s ESG report will encourage the business community to adopt practices that achieve environmental and social sustainability standards."
By adopting these high standards, ADX is in harmony with “Towards the next 50” that charts out the UAE’s strategic development plan which aims to build a sustainable, diversified and high value-added economy that positively contributes to transition to a new global sustainable development paradigm. ADX’s ESG report reinforces the guiding principles on Sustainable Finance and encourages building up investment opportunities while increasing the quality and depth of sustainable investments in the UAE.
About Abu Dhabi Securities Exchange:
Abu Dhabi Securities Exchange (ADX) was established on November 15 of the year 2000 by Local Law No. (3) Of 2000, the provisions of which vest the market with a legal entity of autonomous status, independent finance and management. The Law also provides ADX with the necessary supervisory and executive powers to exercise its functions.
ADX is a market for trading securities; including shares issued by public joint stock companies, bonds issued by governments or corporations, exchange traded funds, and any other financial instruments approved by the UAE Securities and Commodities Authority (SCA).
In 2014, ADX was upgraded to ‘Emerging Market’ status by both MSCI and S&P Dow Jones. ADX was already classified as an Emerging Market by FTSE in 2009 and in 2011 by S&P and Russell Investments.
*Source: AETOSWire
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200114005680/en/
Contact information
Abu Dhabi Securities Exchange (ADX)
Abdulrahman Saleh ALKhateeb, Manager of Corporate Communication & Digital Marketing
Marketing & Corporate Communication Department
Tel: +97126128774
Mobile: +971506689733
Email: ALKhateebA@adx.ae
Newgate Communication
Habib Bacha
Tel: +97124420423
Mobile: +971501113799
Email: habib.bacha@newgatecomms.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 11:00:00 EEST | Press release
OM Pharma will reveal preliminary results from the REACH study at the European Academy of Allergy and Clinical Immunology (EAACI) Congress. REACH is the first and largest multi-country real-world evidence (RWE) study to date evaluating the impact of Broncho-Vaxom® in patients with recurrent respiratory tract infections (RTIs).1,2 The findings offer critical new clinical evidence of the therapy's effectiveness in everyday clinical practice. In a real-world cohort of 15,794 paediatric (aged >1 year), adolescent, adult and elderly patients in China, Italy, and Belgium, Broncho-Vaxom® was associated with reductions in RTI recurrence and healthcare utilisation at 12 and 24 months after treatment initiation, compared with the 12 months prior to starting the therapy.1 “The REACH real-world evidence study shows that Broncho-Vaxom® can significantly reduce infections requiring medical visits across age groups and co-morbidities,” said Anna Thomas, Chief Scientific Officer at OM Pharma. “Recurre
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 18:15:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced updated clinical data from two Phase 1 studies evaluating the safety, tolerability and efficacy of INCA033989, a first-in-class mutant calreticulin (mutCALR)-targeted monoclonal antibody, in patients with mutCALR-expressing myeloproliferative neoplasms (MPNs). INCA033989 demonstrated rapid, clinically meaningful responses and consistent molecular activity across both myelofibrosis (MF) and essential thrombocythemia (ET), with convergent evidence supporting the potential for disease modification. These findings are being presented in oral and poster presentations at the European Hematology Association (EHA) 2026 Congress in Stockholm, Sweden (Session: Myeloproliferative neoplasms – Clinical, Presentation numbers: S216, PS1983, PF884). “The data presented at EHA 2026 demonstrate clinically meaningful and consistent responses with INCA033989 across both myelofibrosis and essential thrombocythemia,” said Pablo J. Cagnoni, M.D., President of Incyte and G
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 13:00:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP, the current standard of care, as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. These data are being highlighted in a prestigious Plenary Abstracts Session at the European Hematology Association (EHA) 2026 Congress, being held June 11 - 14, 2026, in Stockholm, Sweden (Abstract # S101. Plenary Abstract Session. June 13, 6:00 - 7:30 a.m. ET [12:00-1:30 p.m. CEST]). frontMIND results were als
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202613.6.2026 00:31:00 EEST | Press release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 19:36:00 EEST | Press release
IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, strategy, and business transformation. She most recently served as Global Head of Deloitte Digital and previously held senior global leadership roles,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
